Education
About Us
Working with TipRanks
Follow Us
CVS Health Corp (CVS)
:CVS
CVS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$43.56 - $77.34
Previous CloseN/A
Volume5.40M
Average Volume (3M)7.15M
Market Cap
$96.10B
Enterprise Value$156.28B
Total Cash (Recent Filing)$14.22B
Total Debt (Recent Filing)$82.72B
Price to Earnings (P/E)20.8
Beta0.52
Next Earnings
Oct 29, 2025EPS Estimate
1.36Next Dividend Ex-Date
Oct 23, 2025Dividend Yield3.51%
Share Statistics
EPS (TTM)1.81
Shares Outstanding1,268,326,400
10 Day Avg. Volume7,067,151
30 Day Avg. Volume7,153,649
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.63
Enterprise Value/Revenue0.40
Enterprise Value/Gross Profit2.92
Enterprise Value/Ebitda12.01
Forecast
1Y Price Target
$83.81Price Target Upside10.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
Bulls Say, Bears Say
Bulls Say
Healthcare BenefitsThe recovery of the Health Care Benefits segment remains intact, increasing confidence in the longer-term trajectory of the business.
Turnaround PotentialCVS is encouraged by the second year of the Aetna turnaround and successful PBM selling season, which are seen as positive tailwinds.
ValuationCVS is trading at a compelling valuation below the 10-year average despite having an above-average growth trajectory.
Bears Say
Enrollment GrowthCVS is not expecting Medicare Advantage enrollment growth in 2026, which is a concern for investors.
Medicare AdvantageMedicare Advantage long-term target margins were adjusted, reflecting ongoing industry pressures and recent developments.
Stars MetricsLack of clarity on Stars metrics led to investor questions, impacting the stock negatively despite CVS's confidence in areas under its control.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was $43.56 and its highest was $77.34 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $96.10B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Oct 29, 2025 which is in 31 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on Jul 31, 2025. The company reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.458 by $0.352.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.665 which represents an annual dividend yield of 3.51%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.36.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,268,326,400 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $1.81 in its last earnings report, beating expectations of $1.458. Following the earnings report the stock price went down -0.321%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in CVS
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$83.81 (10.61% Upside)
$83.81 (10.61% Upside)
Blogger Sentiment
Bullish
CVS Sentiment 70%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 7.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $532.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 1.5%
Last 30 Days ▼ 1.5%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.28%
12-Months-Change
Fundamentals
Return on Equity
5.95%
Trailing 12-Months
Asset Growth
2.32%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
CVS Company Deck
CVS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a strong revenue growth and solid performance in the Pharmacy and Consumer Wellness segment, alongside improvements in Health Care Benefits. However, challenges remain in the Health Services segment, particularly with Oak Street Health and Group Medicare Advantage, which have pressured the overall results. Despite these challenges, the company's outlook remains positive with an increased EPS guidance.View all CVS earnings summariesCVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
$83.81
▲(10.61% Upside)
Technical Analysis
Ownership Overview
0.72% Insiders
33.14% Mutual Funds
28.20% Other Institutional Investors
17.01% Public Companies and Individual Investors